CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Financial incentive for colorectal cancer screening +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06124131
NCT06124131N/ACompleted
CompareCT.gov

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Tulane University·interventional·Posted Nov 9, 2023·Updated May 4, 2025

In Brief

A clinical study evaluating Financial incentive for colorectal cancer screening, Financial incentive for flu shot, and 1 other intervention for Health Behavior and 6 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealth Behavior, Colorectal Cancer, Influenza, COVID-19, Vaccine Hesitancy, Vaccine-Preventable Diseases, Healthcare Patient Acceptance
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
202420252026
First PostedNov 9, 2023
Enrollment StartNov 11, 2023
Primary CompletionMar 25, 2024
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.6 years ago

Interventions

Financial incentive for colorectal cancer screeningbehavioral

$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment

Financial incentive for flu shotbehavioral

$50 incentive paid to participant for completion of flu shot within 2 months of enrollment

Financial incentive for COVID-19 shotbehavioral

$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment